Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

802539

registered interest
date	07/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what targets his Department has set for reducing childhood obesity over the course of the 2017 Parliament.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	118089
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>Our world-leading childhood obesity plan, launched in August 2016, aims to significantly reduce England’s rate of childhood obesity within the next 10 years.</p><p> </p><p>A copy of “Childhood Obesity: A Plan for Action” is attached and is available at:</p><p><a href="http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/546588/Childhood_obesity_2016__2__acc.pdf" target="_blank">www.gov.uk/government/uploads/system/uploads/attachment_data/file/546588/Childhood_obesity_2016__2__acc.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2017 12:32:12 answering member 4067 label Biography information for Steve Brine attachment 1 file name Childhood Obesity Plan.pdf title PQ118089
tabling member	1409 label Biography information for Mr Gregory Campbell

802550

registered interest
date	07/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Inflammatory Bowel Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to increase the proportion of patients with inflammatory bowel disease who receive support and information in primary care and acute care to enable them to self-manage.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	118100
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>Inflammatory bowel disease (IBD) is the collective name used to describe ulcerative colitis and Crohn’s disease. To support commissioners to deliver local services for people with Crohn’s disease and ulcerative colitis, the National Institute for Health and Care Excellence (NICE) published, ‘Crohn’s Disease Management in Adults, Children and Young People’, updated in May 2016, and, ‘Ulcerative Colitis Management in Adults, Children and Young People’, in June 2013.</p><p> </p><p>The NICE Crohn’s clinical guideline makes clear that minimising psychological concerns and possible side effects of treatment are a key part of best practice for all people with Crohn's disease. The NICE Ulcerative Colitis clinical guideline highlights psychological support as being particularly important if a patient is considering surgery for their disease, and post-operatively, when surgery has taken place. Patient education, information and support are priorities in both guidelines. This can cover important information about diet and lifestyle, treatment and side-effects, as well signposting to support groups and other relevant services. Both guidelines can be found at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152" target="_blank">www.nice.org.uk/guidance/cg152</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166" target="_blank">www.nice.org.uk/guidance/cg166</a></p><p> </p><p>The IBD audit programme was established over 10 years ago with the aim of improving the quality and safety of care for people with IBD throughout the United Kingdom and during this time it has delivered important improvements against NICE standards. Audit reports have covered both treatment and patient experience, the latter of which captured information about quality of information and support at discharge, to help drive improvement in this area. In 2015, eight regional service improvement workshops were conducted by the IBD programme team to share expertise and examples of best practice, and to develop action plans to implement and evaluate improvement in IBD services. Attended by clinicians from across the country, a range of improvement initiatives were taken forward as a result, including around patient information and self-management. The report evaluating this important work and more information on the audit can be found at the following link:</p><p><a href="http://www.rcplondon.ac.uk/projects/ibd-programme" target="_blank">www.rcplondon.ac.uk/projects/ibd-programme</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2017 14:00:51 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

802709

registered interest
date	07/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Life Sciences
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to page 13 of the life sciences sector deal published on 6 December 2017, what steps the Government plans to take to improve NHS England’s commercial capacity and capability.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	118258
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>The Government and its partner bodies, including NHS England, recently published the response to the Accelerated Access Review setting out plans to improve NHS England’s commercial capacity and capability in relation to medicines procurement as well as the negotiation of bespoke commercial access arrangements for high cost drugs.</p><p> </p><p>While establishing this commercial function is an operational matter for NHS England, the Government has already taken steps to support this process by transferring the Commercial Medicines Unit from the Department to NHS England on 1 April 2017. In addition, transferring the role of agreeing future Patient Access Schemes (PAS) from the Department to NHS England means that companies need to begin only one dialogue for each medicine.</p><p> </p><p>NHS England is currently in the process of recruiting a number of other key posts to support this commercial function more broadly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2017 17:15:26 answering member 4067 label Biography information for Steve Brine
tabling member	4124 label Biography information for Chi Onwurah

802753

registered interest
date	07/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Transport
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 7 December to Question 116360, for what reason the Department has no plans to review patient transport guidance; and if he will make a statement
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	118302
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>The provision of appropriate patient transport services is a matter for local National Health Service commissioners, who are best placed to make effective decisions about such services to meet the specific needs of their local populations. Accordingly, there are currently no plans to review patient transport service eligibility guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2017 17:12:34 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

802131

registered interest
date	06/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what changes there have been in the (a) assessment and (b) management of motor neurone disease in the last 12 months.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	117818
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>On 24 February 2016, the National Institute for Health and Care Excellence (NICE) published a new best practice guideline on the assessment and management of motor neurone disease (MND) and in July 2016 published a corresponding Quality Standard (QS), which sets out five key markers of high quality MND care. NICE routinely reviews its guidance to ensure that it reflects the latest available evidence, and it reviewed its QS earlier this year. Both the guideline and QS, along with information about the next planned review dates for both, can be found at the following links:</p><p><a href="http://www.nice.org.uk/guidance/ng42/resources/motor-neurone-disease-assessment-and-management-1837449470149" target="_blank">www.nice.org.uk/guidance/ng42/resources/motor-neurone-disease-assessment-and-management-1837449470149</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/qs126" target="_blank">www.nice.org.uk/guidance/qs126</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:45:13 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

802144

registered interest
date	06/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate his Department has made of number of adults annually giving up smoking as a result of vaping; and whether there has been an increase in the number of adults giving up smoking since vaping became more common practice.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	117831
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The Office for National Statistics has published data on e-cigarette use in England annually since 2014. Data is published at the following link:</p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/ecigaretteuseinengland" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/ecigaretteuseinengland</a></p><p>The statistics show that in 2014 there was a total of 1.6 million e-cigarette users with 0.6 million of those ex-cigarette smokers. In 2016 e-cigarette use had increased to 2.4 million users, with 1.3 million of those ex-cigarette smokers. Smoking prevalence in England is currently at 15.5%, the lowest it has ever been.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:38:30 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

802274

registered interest
date	06/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Fracking: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with Public Health England on updating its report of 2014 on the effect of shale gas on public health.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	117961
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>Public Health England (PHE) reviews the evidence base on the health impacts of chemical and radiological emissions associated with shale gas extraction as it emerges, considering the available evidence as a whole. Currently, PHE has not identified any significant new evidence that would make the Department change its view that the potential risks to public health from exposure to emissions associated with shale gas extraction will be low if operations are properly run and regulated. This means that good on-site management and appropriate regulation of all aspects from exploratory drilling, gas capture, use and storage of fracking fluid, and post-operations decommissioning are essential to minimise the risk to the environment and public health. If significant new evidence emerged this would be discussed with the Department of Health and other Government departments.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:35:39 answering member 4067 label Biography information for Steve Brine
tabling member	3998 label Biography information for Mark Menzies

800927

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drug: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Advisory Council on the Misuse of Drugs report Commissioning impact on drug treatment which published in September 2017, what assessment he has made of the effect of reductions in funding for local authorities on the availability of drug misuse treatment in England.
tabling member constituency	Manchester, Withington
tabling member printed	Jeff Smith
uin	117486
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>Officials are currently reviewing the report by the Advisory Council on the Misuse of Drugs entitled Commissioning impact of on drug treatment published on 6 September. The Government will respond shortly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:39:29 answering member 4067 label Biography information for Steve Brine
tabling member	4456 label Biography information for Jeff Smith

800952

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of trends in the rates of prostate cancer among men over 50 who are (a) white and (b) BAME during the last ten years.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	117511
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>Data on the rates of prostate cancer among men over 50 are not held in the format requested.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:37:22 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

800962

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Infant Foods: Marketing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health what assessment he has made of the potential merits of fully implementing the International Code of Marketing of Breastmilk Substitutes after the UK leaves the EU.
tabling member constituency	Glasgow Central
tabling member printed	Alison Thewliss
uin	117521
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The Infant Formula and Follow-on Formula Regulations 2007 implements European Commission Directive 2006/141/EC on infant formulae and follow-on formulae, which gives effect to the principles and aims of the 1981 World Health Organization Code on the Marketing of Breastmilk Substitutes dealing with marketing, information and responsibilities of health authorities. There are no plans to review this legislation after the United Kingdom leaves the European Union.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:40:18 answering member 4067 label Biography information for Steve Brine
tabling member	4430 label Biography information for Alison Thewliss